Aggressive Spinal Hemangioma

Management Of Aggressive Spinal Hemangioma

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06996873

Enrollment

Registered

2025-05-30

Start date

2025-06-30

Completion date

2026-12-30

Last updated

2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aggressive Spinal Hemangiomas

Keywords

hemangiomas, management

Brief summary

This research is a case series analysis to evaluate aggressive vertebral hemangiomas. It focuses on clinical presentation, diagnostic imaging accuracy (X-ray, MRI, MSCT, angiography), and treatment efficacy. The primary goal is to establish optimal management protocols.

Detailed description

Hybrid methodology integrating retrospective case reviews (from Assiut University Hospital's Orthopedic Surgery Department) with synthesis of existing literature. Objectives: Characterize clinical presentations and imaging findings. Compare diagnostic accuracy across modalities. Analyze treatment outcomes, including procedural success rates and complications. Tools: Imaging: X-ray for initial screening, MRI/MSCT for soft tissue and spinal cord involvement, angiography for vascular mapping.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients diagnosed with aggressive spinal hemangiomas based on clinical symptoms and imaging findings. * Cases confirmed through diagnostic modalities such as X-ray, MRI, MSCT, or angiography. * Patients presenting with symptoms such as pain, neurological deficits, or spinal instability attributable to the hemangioma.

Exclusion criteria

* Patients with incidentally discovered spinal hemangiomas (asymptomatic cases found during evaluations for unrelated conditions). * Cases lacking sufficient diagnostic evidence to confirm aggressive spinal hemangioma.

Design outcomes

Primary

Measure	Time frame	Description
Neurological Symptom Resolution	3 months	using the Pain intensity (VAS scale)

Secondary

Measure	Time frame	Description
Functional Status Improvement	3 months	using ASIA Impairment Scale (primary) Threshold: ≥1-grade improvement on ASIA scale sustained for ≥3 months

Outcome results